ctrl K

Price Alert

GeneDx Corp. (WGS)

NASDAQ: WGS · Real-Time Price · USD

126.31

3.43 (2.79%)

At close: Aug 15, 2025, 3:59 PM

125.50

-0.64%

After-hours: Aug 15, 2025, 06:52 PM EDT

GeneDx Balance Sheet Statement

Financials in USD. Fiscal year is undefined.

Fiscal Year	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021
Cash & Equivalents	85.21M	99.68M	123.93M	400.57M
Short-Term Investments	55.97M	30.47M	n/a	n/a
Long-Term Investments	n/a	987K	900K	900K
Other Long-Term Assets	4.31M	58.34M	-47.83M	6.93M
Receivables	37.63M	32.82M	43.34M	26.56M
Inventory	10.65M	8.78M	13.66M	33.46M
Other Current Assets	1.08M	10.6M	6.39M	3.8M
Total Current Assets	197.97M	182.34M	212.62M	483.54M
Property-Plant & Equipment	58.51M	59.38M	84.28M	62.72M
Goodwill & Intangibles	158.6M	172.63M	186.65M	n/a
Total Long-Term Assets	221.41M	291.33M	278.32M	70.55M
Total Assets	419.38M	473.67M	490.94M	554.09M
Account Payables	7.95M	10.24M	46.02M	44.69M
Deferred Revenue	n/a	n/a	40K	473K
Short-Term Debt	n/a	497K	4.75M	n/a
Other Current Liabilities	41.92M	30.12M	67.08M	22.49M
Total Current Liabilities	54.82M	58.82M	144.3M	101.28M
Long-Term Debt	51.91M	52.69M	6.25M	11M
Other Long-Term Liabilities	5.52M	69.65M	24.02M	53.71M
Total Long-Term Liabilities	119.32M	186.84M	92.94M	64.71M
Total Liabilities	174.13M	245.66M	237.24M	165.99M
Total Debt	116.17M	119.77M	72.38M	32.85M
Common Stock	2K	2K	38K	24K
Retained Earnings	-1.35B	-1.3B	-1.12B	-575.44M
Comprehensive Income	830K	425K	n/a	n/a
Shareholders Equity	245.25M	228.02M	253.71M	388.1M
Total Investments	55.97M	31.45M	900K	900K